Showing 1 posts of 1 posts found.
Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
Ondine reports 40% reduction in surgical-site infections in phase 3 trial
Northern Ireland to roll out staff well-being training across health service
European consortium demonstrates continuous manufacturing platform for pharmaceutical ingredients